IO Biotech Inc has a consensus price target of $9, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co. on March 6, 2024, September 28, 2023, and September 13, 2023. With an average price target of $8.67 between HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co., there's an implied 532.60% upside for IO Biotech Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for IO Biotech (NASDAQ: IOBT) was reported by HC Wainwright & Co. on March 6, 2024. The analyst firm set a price target for $8.00 expecting IOBT to rise to within 12 months (a possible 483.94% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for IO Biotech (NASDAQ: IOBT) was provided by HC Wainwright & Co., and IO Biotech reiterated their buy rating.
There is no last upgrade for IO Biotech.
There is no last downgrade for IO Biotech.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IO Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IO Biotech was filed on March 6, 2024 so you should expect the next rating to be made available sometime around March 6, 2025.
While ratings are subjective and will change, the latest IO Biotech (IOBT) rating was a reiterated with a price target of $0.00 to $8.00. The current price IO Biotech (IOBT) is trading at is $1.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.